Ross R.Atherosclerosis--an inflammatory diseaseNew England Journal of Medicine1999; 14;340(2):115-26.
2.
Gerrity RGThe role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. American Journal of Pathology1981;103(2):181-90.
3.
Gerrity RG, Goss JA, Soby L.Control of monocyte recruitment by chemotactic factor(s) in lesion-prone areas of swine aorta. Arteriosclerosis1985 ; 5(1):55-66.
4.
Beall CJ, Breckenridge SM, Chakravarty L., Kolattukudy PEExpression of human monocyte chemoattractant protein-1 in the yeast Pichia pastoris. Protein Expression & Purification1998;12(2):145-50.
Strawn W., Gallagher P., Tallant E., Ganten D., Ferrario CMAngiotensin AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats. J Cardiovasc Pharmacol1999;33:341-51.1.
7.
Sugano M.,Makino N.,Yanaga T.The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits. Athero1996;127:123-9.
8.
Zimmerman B. , Dunham E.Tissue renin-angiotensin system: a site of drug action?Ann Rev Pharmacol Toxicol1997 ;37:53-69.
9.
Kleinert S.HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation. Lancet1999 ;354(9181):841.
10.
Dickstein K. , Kjekshus J.Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan. American Journal of Cardiology1999;83(4):477-81. 1.
11.
Strawn W., Chappell MC, Dean RH, Kivlighn SD, Ferrario CMInhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation2000;101(in press).
12.
Chisi JE, Wdzieczak-Bakala J.,Thierry J., Briscoe CV, Riches ACCaptopril inhibits the proliferation of hematopoietic stem and progenitor cells in murine long-term bone marrow cultures. Stem Cells1999;17(6):339-44.
13.
Diet F., Pratt RE, Berry GJ, Momose N., Gibbons GH, Dzau VJ - Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation1996 Dec 1;94(11):2756-67.
14.
Ohishi M., Ueda M., Rakugi H. et al. Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans. Journal of Hypertension1997;15(11):1295-302.
15.
Ohishi M., Ueda M., Rakugi H. et al. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. Circulation1997;96(10):3328-37.
16.
Berkenboom G.Unstable atherosclerotic plaque. Pathophysiology and therapeutic guidelines. Acta Cardiologica1998;53(4):235-41.
17.
Ford CM, Li S., Pickering JGAngiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT1-receptor, transforming growth factor-beta, and tyrosine phosphorylation. Arteriosclerosis, Thrombosis & Vascular Biology1999;19(8):1843-51.1.
18.
Weitkamp B. , Cullen P., Plenz G., Robenek H., Rauterberg J.Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque. FASEB Journal1999;13(11):1445-57.
19.
Dixon IM, Ju H., Reid NL, Scammell-La FT, Werner JP, Jasmin G.Cardiac collagen remodeling in the cardiomyopathic Syrian hamster and the effect of losartan. Journal of Molecular & Cellular Cardiology1997;29(7):1837-50.
20.
Fukuhara M. , Geary RL, Diz DI et al. Angiotensin-converting enzyme expression in human carotid artery atherosclerosis. Hypertension2000;35(S1,part2):353-9. 21.
21.
Keidar S. Angiotensin, LDL peroxidation and atherosclerosis . Life Sci1998;63:111.
22.
Ferrario CM , Deitch JS, Dean RH, Strawn WBHypertension and atherosclerosis: a mechanistic understanding of disease progression. Cardiovasc Risk Factors1996;6(6):1-12.
23.
Peeters AC, Netea MG, Kullberg BJ,ThienT.,van der Meer JWThe effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology1998;94(3):376-9.
24.
Kim JA, Berliner JA, Nadler JL. Angiotensin II increases monocyte binding to endothelial cells . Biochem Biophys Res Comm1996;226(3):862-8.
25.
Wiener J., Lombardi DM, Su JE, Schwartz SMImmunohistochemical and molecular characterization of the differential response of the rat mesenteric microvasculature to angiotensin-II infusion . J Vasc Res1996;33:195-208.
26.
Nickenig G. , Jung O., Strehlow K. et al. Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression. Am J Physiol1997;272:H2701-H2707
27.
Nickenig G. , Sachindis A., Michaelsen F., Böhm M., Seewald S., Vetter H.Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells . Circ1997 ;95(2):473-8.
28.
Keidar S., Kaplan M., Aviram M. Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation. Arterioscler Throm Vasc Biol1996;16(1):97-105.
29.
Nakashima Y. , Raines E., Plump A., Breslow J., Ross R.Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterio Thromb Vasc Biol1998;18:842-51.1.
30.
Martin T.,Cardarelli P., Parry G., Felts K., Cobb R.Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depend on the cooperative action of NF-κB and AP-1. Eur J Immunol1997;27:1091-7.
31.
Hernandez-Presa M., Bustos C., Ortego M. et al. Angtiotensin-converting enzyme prevents arterial nuclear factor kappa-B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation1997 ;95:1532-41.
32.
Gräfe M.,Auch-Schwelk W., Zakrzewicz A. et al. Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res1997;81:804-11.
33.
Pal A., Ueland T., Muller F. et al. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circ1998;97:1136-43.
34.
De Caterina R., Basta G., Lazzarini G. et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterio Thromb Vasc Biol1997;17:2646-54.
35.
Morisaki N. , Saito I.,Tamura K. et al. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease . Athero1997;131:43-8.
36.
Peter K., Nawroth P., Conradt C. et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterio Thromb Vasc Biol1997;17:505-12.
37.
Stary HC, Chandler AB, Glagov S. et al. A definition of initial fatty streak and intermediate lesions of atherosclerosis. Arterioscler Thromb1994 ;14(5):840-56.
38.
Chobanian AV , Haudenschild CC, Nickerson C., Drago R.Anti-atherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension1990;1:327-31.
39.
Chobanian AV , Haudenschild CC, Nickerson C., Hope S.Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Hypertension1992;20:473-7.
40.
Hope S., Brecher P., Chobanian AVComparison of the effects of AT1-receptor blockade and angiotensin converting enzyme inhibtion on atherosclerosis. Am J Hyperten1999;12:28-34.
41.
Keidar S.,Attias J., Smith J., Breslow J., Hayek T.The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Comm1997;236:622-5.
42.
Smith JD, Breslow JLThe emergence of mouse models of atherosclerosis and their relevance to clinical research. Journal of Internal Medicine1997 ;242(2):99-109.
43.
Aliev G., Burnstock G.- Watanabe rabbits with heritable hypercholesterolemia: a model of atherosclerosis . Histology & Histopathology1998; 13(3):797-8177.
Best RG, Diamond D., Crawford E. et al. Baboon/human homologies examined by spectral karyotyping (SKY): a visual comparison. Cytogenetics & Cell Genetics1998;82(1-2):83-7.
46.
Clarkson TB , Hughes CL, Klein KPThe nonhuman primate model of the relationship between gonadal steroids and coronary heart disease . Progress in Cardiovascular Diseases1995 ;38(3):189-98.
47.
Weingand KWAtherosclerosis research in cynomolgus monkeys (Macaca fascicularis). Experimental & Molecular Pathology1989;50(1):1-155.
48.
Wagner J., Schwenke D., Zhang L., Applebaum-Bowden D., Bagdade J., Adams M.Effects of short-term hormone replacement therapies on low-density lipoprotein metabolism in cynomolgus monkeys. Arterio Thromb Vasc Biol1997;17:1128-34. 49. Song K., Shiota N.,Takai S. et al. Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed cynomolgus monkeys. Athero1998;138:171-82.
49.
Soejima H., Ogawa H.,Yasue H. et al. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction . Journal of the American College of Cardiology1999;34(4):983-8.
50.
Dawson TC, Kuziel WA, Osahar TA, Maeda N.Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis1999;143(1):205-11.1.
51.
Aiello RJ, Bourassa PA, Lindsey S. et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis & Vascular Biology1999;19(6):1518-25.
52.
Chen XL,Tummala PE, Olbrych MT,Alexander RW, Medford RM. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circulation Research1998;83(9):952-9.
53.
Raiden S., Giordano M.,Andonegui G. et al. Losartan, a selective inhibitor of subtype AT1-receptors for angiotensin II, inhibits the binding of N-formylmethiolnylleucyl-phenylalanine to neutrophil receptors. JPET1997;281(2):624-8.
54.
Meuret G., Bammert J., Hoffmann G.Kinetics of human monocytopoiesis. Blood1974 ;44(6):801-16.
55.
Otani I.,Akari H., Nam K.-H et al. Phenotypic changes in peripheral blood monocytes of cynomolgus monkeys acutely infected with simian immunodeficiency virus. AIDS Res Human Retrovir1998;14:1181-6.
56.
Averill LE, Meagher RC, Gerrity RGEnhanced monocyte progenitor cell proliferation in bone marrow of hyperlipemic swine. American Journal of Pathology1989;135(2):369-77.
57.
RotheG.,HerrAS,StohrJ.,AbletshauserC.,WeidingerG.,SchmitzG.Amoremature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease. Atherosclerosis1999;144(1):251-61.
58.
Banda MA, Lefer DJ, Granger DNPostischemic endothelium-dependent vascular reactivity is preserved in adhesion molecule-deficient mice. American Journal of Physiology1997;273(6 Pt 2):H2721-5.
59.
Noble KE, Panayiotidis P., Collins PW, Hoffbrand AV,Yong KLMonocytes induce E-selectin gene expression in endothelial cells: role of CD11b/CD18 and extracellular matrix proteins. European Journal of Immunology1996; 26(12):2944-51.1.
60.
Rothe G., Gabriel H., Kovacs E. et al. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterio Thromb Vasc Biol1996;16:1437-47.
61.
Lehr HA,Vollmar B.,Vajkoczy P., Menger MDIntravital fluorescence microscopy for the study of leukocyte interaction with platelets and endothelial cells. Oxidants and Antioxidants, PT B1999;300:462-481.
62.
Serrano CVJ , Ramires JA, Venturinelli M. et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. Journal of the American College of Cardiology1997;29(6):1276-83.
63.
de Servi S. , Mazzone A., Ricevuti G. et al. Expression of neutrophil and monocyte CD11b/CD18 adhesion molecules at different sites of the coronary tree in unstable angina pectoris. American Journal of Cardiology1996;78(5):564-8.
64.
Rovers C., Netea MG, de Bont N. et al. LPS-induced cytokine production and expression of beta2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia. Atherosclerosis1998;141(1):99-105.
65.
Weber C., Erl W., Weber KS, Weber PCHMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. Journal of the American College of Cardiology1997;30(5):1212-7.
66.
Keidar S.,Attias J., Heinrich R., Coleman R., Aviram M.Angiotensin II atherogenicity in apolipoprotein E-deficient mice is associated with increased cellular cholesterol biosynthesis. Atherosclerosis1999;146(2):249-57.
67.
Weber KT, Swamynathan SK, Guntaka RV, Sun Y. Angiotensin II and extracellular matrix homeostasis. International Journal of Biochemistry & Cell Biology1999 ;31(3-4):395-403.
68.
Haznedaroglu ICA local renin--angiotensin system in the bone marrow: hypothesis and clues. Experimental Hematology1999;27(1):186-7.
69.
del Castillo D., Campistol JM, Guirado L. et al. Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients . Kidney International - Supplement1998 ;68:S135-9.
70.
Wulf GG, Jahns-Streubel G., Strutz F. et al. Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells. Annals of Hematology1996;73(3):139-41.
71.
Mrug M., Stopka T., Julian BA, Prchal JF, Prchal JT. Angiotensin II stimulates proliferation of normal early erythroid progenitors. Journal of Clinical Investigation1997;1;100(9):2310-4.
72.
Farokhzad OC , Shelley CS,Arnaout MAInduction of the CD11b gene during activation of the monocytic cell line U937 requires a novel nuclear factor MS-2. Published erratum appears in J Immunol1999; 15;163(2):1091.
73.
Anderson KL , Smith KA, Perkin H. et al. PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation. Blood1999; 1;94(7):2310-8.
74.
Klahr S., Morrissey J. Angiotensin II and gene expression in the kidney. American Journal of Kidney Diseases1998;31(1):171-6.
75.
Papayannopoulou T., Craddock C.Homing and trafficking of hemopoietic progenitor cells. Acta Haematologica1997;97(1-2):97.
76.
Wilkins BS, Jones DBCell-stroma interactions in monocytopoiesis. FEMS Microbiology Immunology1992;5(5-6):347-53.
77.
Nabeshima R. ,Aizawa S., Nakano M. et al. Effects of vesnarinone on the bone marrow stromal cell-dependent proliferation and differentiation of HL60 cells in vitro. Experimental Hematology1997;25(6):509-15.
78.
McKercher SR , Henkel GW, Maki RAThe transcription factor PU.1 does not regulate lineage commitment but has lineage-specific effects . Journal of Leukocyte Biology1999;66(5):727-732.
79.
Berk BCAngiotensin IIsignal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases. Journal of the American Society of Nephrology1999;10 (Suppl 11):S62-8.
80.
Nakano N., Moriguchi A., Morishita R. et al. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats . Hypertension1997;30(6):1448-54.
81.
Matsumoto K. , Morishita R., Moriguchi A. et al. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats. Hypertension1999;34(2):279-84.
82.
Morishita R. ,Aoki M., Nakamura S. et al. Potential role of a novel vascular modulator, hepatocyte growth factor (HGF), in cardiovascular disease: characterization and regulation of local HGF system. Journal of Atherosclerosis & Thrombosis1997;4(1):12-9.
83.
Aoyagi M.,Yamamoto S.,Azuma H. et al. Localization and effects of hepatocyte growth factor on smooth muscle cells during neointimal formation after balloon denudation. Histochemistry & Cell Biology1999;111(6):419-28.
84.
Yoshimura M. , Sakurabayashi I.Introductory review of diagnostic approach to arteriosclerosis. Rinsho Byori: Japanese Journal of Clinical Pathology1998; 46(7):663-5.
85.
Tomida M., Heike T., Yokota T.Cytoplasmic domains of the leukemia inhibitory factor receptor required for STAT3 activation, differentiation, and growth arrest of myeloid leukemic cells . Blood1999; 15;93(6):1934-41.
86.
Phillips MI , Mohuczy-Dominiak D., Coffey M. et al. Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense. Hypertension1997; 29(1 Pt 2):374-80.